Skip to content

Intraperitoneal bupivacaine's instillation (IP) with dexmedetomidine vs intraperitoneal bupivacaine's for postoperative pain management in laparoscopic Hysterectomy

Intraperitoneal analgesia to reduce pain after laparoscopic Hysterectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202406806682730
Enrollment
30
Registered
2024-06-06
Start date
2021-09-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

laparoscopic hysterectomy

Interventions

Group B Bupivacaine HCL Marcaine alone n 15
Group A Bupivacaine HCL Dexmedetomidine Precedex n 15

Sponsors

Ain Shams University Maternity Hospital and Adam International Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: patients indicated for laparoscopic hysterectomy at our hospital for any gynecological indication

Exclusion criteria

Exclusion criteria: 1- history of chronic opioid intake (due to opioid-induced tolerance &Hyperalgesia). 2-large Uterus (= 12 gestational week), which could lead to surgical difficulties. 3- renal failure (bupivacaine contraindicated in RF due to the hypotension). 4-chronic alcoholism (increase dose requirement of local anesthesia). 5- heart block (due to bupivacaine side effect of cardiotoxicity) 6-history of left ventricular failure (due to bupivacaine side effect of cardiotoxicity and hypotension). 7- patients taking beta-blocking drugs (due to bupivacaine side effect of hypotension) 8-allergy to the study drugs. 9-patient is enrolled in another pain management study.

Design outcomes

Primary

MeasureTime frame
The primary outcome: Postoperative pain scores in the first 24 hours

Secondary

MeasureTime frame
The Secondary outcomes: nausea and Vomiting, the need for post-operative rescue analgesia 1st 24 hours, and length of hospital stay

Countries

Egypt

Contacts

Public ContactAhmed Sherif

lecturer obestatrics and gynecology Ain Shams University

Cairotrade2050@gmail.com+201127884439

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026